Literature DB >> 35389253

Staphylococcus aureus Overcomes Anaerobe-Derived Short-Chain Fatty Acid Stress via FadX and the CodY Regulon.

Joshua R Fletcher1, Alex R Villareal1, Mitchell R Penningroth1, Ryan C Hunter1.   

Abstract

Chronic rhinosinusitis (CRS) is characterized by immune dysfunction, mucus hypersecretion, and persistent infection of the paranasal sinuses. While Staphylococcus aureus is a primary CRS pathogen, recent sequence-based surveys have found increased relative abundances of anaerobic bacteria, suggesting that S. aureus may experience altered metabolic landscapes in CRS relative to healthy airways. To test this possibility, we characterized the growth kinetics and transcriptome of S. aureus in supernatants of the abundant CRS anaerobe Fusobacterium nucleatum. While growth was initially delayed, S. aureus ultimately grew to similar levels as in the control medium. The transcriptome was significantly affected by F. nucleatum metabolites, with the agr quorum sensing system notably repressed. Conversely, expression of fadX, encoding a putative propionate coenzyme A (CoA)-transferase, was significantly increased, leading to our hypothesis that short-chain fatty acids (SCFAs) produced by F. nucleatum could mediate S. aureus growth behavior and gene expression. Supplementation with propionate and butyrate, but not acetate, recapitulated delayed growth phenotypes observed in F. nucleatum supernatants. A fadX mutant was found to be more sensitive than wild type to propionate, suggesting a role for FadX in the S. aureus SCFA stress response. Interestingly, spontaneous resistance to butyrate, but not propionate, was observed frequently. Whole-genome sequencing and targeted mutagenesis identified codY mutants as resistant to butyrate inhibition. Together, these data show that S. aureus physiology is dependent on its cocolonizing microbiota and metabolites they exchange and indicate that propionate and butyrate may act on different targets in S. aureus to suppress its growth. IMPORTANCE Staphylococcus aureus is an important CRS pathogen, and yet it is found in the upper airways of 30% to 50% of people without complications. The presence of strict and facultative anaerobic bacteria in CRS sinuses has recently spurred research into bacterial interactions and how they influence S. aureus physiology and pathogenesis. We show here that propionate and butyrate produced by one such CRS anaerobe, namely, Fusobacterium nucleatum, alter the growth and gene expression of S. aureus. We show that fadX is important for S. aureus to resist propionate stress and that the CodY regulon mediates growth in inhibitory concentrations of butyrate. This work highlights the possible complexity of S. aureus-anaerobe interactions and implicates membrane stress as a possible mechanism influencing S. aureus behavior in CRS sinuses.

Entities:  

Keywords:  Fusobacterium; Staphylococcus aureus; anaerobes; microbiome; short-chain fatty acids; sinusitis

Mesh:

Substances:

Year:  2022        PMID: 35389253      PMCID: PMC9112931          DOI: 10.1128/jb.00064-22

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.476


  38 in total

Review 1.  CodY, a master integrator of metabolism and virulence in Gram-positive bacteria.

Authors:  Shaun R Brinsmade
Journal:  Curr Genet       Date:  2016-10-15       Impact factor: 3.886

2.  Development of a HPLC-UV method for the quantitative determination of four short-chain fatty acids and lactic acid produced by intestinal bacteria during in vitro fermentation.

Authors:  S De Baere; V Eeckhaut; M Steppe; C De Maesschalck; P De Backer; F Van Immerseel; S Croubels
Journal:  J Pharm Biomed Anal       Date:  2013-02-28       Impact factor: 3.935

3.  Inactivation of the Pta-AckA pathway causes cell death in Staphylococcus aureus.

Authors:  Marat R Sadykov; Vinai C Thomas; Darrell D Marshall; Christopher J Wenstrom; Derek E Moormeier; Todd J Widhelm; Austin S Nuxoll; Robert Powers; Kenneth W Bayles
Journal:  J Bacteriol       Date:  2013-04-26       Impact factor: 3.490

4.  Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States.

Authors:  Neil Bhattacharyya
Journal:  Ann Otol Rhinol Laryngol       Date:  2011-07       Impact factor: 1.547

5.  Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis.

Authors:  Leah M Feazel; Charles E Robertson; Vijay R Ramakrishnan; Daniel N Frank
Journal:  Laryngoscope       Date:  2012-01-17       Impact factor: 3.325

6.  Growth pH and transient increases in amino acid availability influence polyglucose synthesis by Fusobacterium nucleatum grown in continuous culture.

Authors:  Peter S Zilm; Neville J Gully; Anthony H Rogers
Journal:  FEMS Microbiol Lett       Date:  2002-10-08       Impact factor: 2.742

7.  Gene expression differences in nitric oxide and reactive oxygen species regulation point to an altered innate immune response in chronic rhinosinusitis.

Authors:  Camille Jardeleza; Damien Jones; Leonie Baker; Dijana Miljkovic; Samuel Boase; Neil Cheng-Wen Tan; Sarah Vreugde; Lor Wai Tan; Peter-John Wormald
Journal:  Int Forum Allergy Rhinol       Date:  2012-11-07       Impact factor: 3.858

8.  Staphylococcus aureus CodY negatively regulates virulence gene expression.

Authors:  Charlotte D Majerczyk; Marat R Sadykov; Thanh T Luong; Chia Lee; Greg A Somerville; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

9.  Staphylococcus aureus from patients with chronic rhinosinusitis show minimal genetic association between polyp and non-polyp phenotypes.

Authors:  Jake Jervis Bardy; Derek S Sarovich; Erin P Price; Eike Steinig; Steven Tong; Amanda Drilling; Judy Ou; Sarah Vreugde; Peter-John Wormald; Alkis J Psaltis
Journal:  BMC Ear Nose Throat Disord       Date:  2018-10-16
View more
  1 in total

1.  Targeting the Achilles' Heel of Multidrug-Resistant Staphylococcus aureus by the Endocannabinoid Anandamide.

Authors:  Ronit Vogt Sionov; Shreya Banerjee; Sergei Bogomolov; Reem Smoum; Raphael Mechoulam; Doron Steinberg
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.